Breaking News Instant updates and real-time market news.

BIO

Bio-Rad

$254.00

-3.85 (-1.49%)

16:27
02/27/18
02/27
16:27
02/27/18
16:27

Bio-Rad sees FY18 revenue growth of 3.5%-4.0%, consensus $2.27B

For the full year 2018, the company anticipates currency neutral revenue growth of approximately 3.5 to 4.0 percent and improved profitability with a currency neutral operating margin target of 10 percent. "Looking ahead to 2018, we expect another year of growth in many of our key product areas and geographies," CEO Norman Schwartz said. "The anticipated expansion in our operating margin for 2018 represents a significant step toward achieving our longer term goal of an EBITDA margin of 20 percent or better in 2020. Moreover, we will continue to look for ways to deploy our capital in a manner that enhances long-term shareholder value."

  • 27

    Feb

BIO Bio-Rad
$254.00

-3.85 (-1.49%)

11/29/17
DBAB
11/29/17
NO CHANGE
Target $300
DBAB
Buy
Bio-Rad shares still have room to run, says Deutsche Bank
Deutsche Bank analyst Dan Leonard left Bio-Rad Laboratories' first ever analyst day "incrementally more optimistic" about the company's ability to meet its 2020 profitability target. The analyst believes the shares have more room to run and he upped his price target for the stock to $300 from $290. Leonard says Bio-Rad remains a top pick.
11/29/17
WELS
11/29/17
NO CHANGE
Target $290
WELS
Outperform
Bio-Rad price target raised to $290 from $250 at Wells Fargo
Wells Fargo analyst Tim Evans raised his price target for Bio-Rad to $290 from $250 following the company's Analyst Day, which was mostly as expected. He reiterates an Outperform rating on the shares.
02/16/18
KING
02/16/18
DOWNGRADE
KING
Neutral
Bio-Rad downgraded to Neutral from Buy at CL King
02/22/18
JEFF
02/22/18
NO CHANGE
Target $300
JEFF
Buy
Jefferies sees low valuation and expectations into Bio-Rad's Q4 print
Jefferies analyst Brandon Couillard says Bio-Rad Laboratories' valuation is low and expectations appear low while the company's fundamentals are improving. He thinks the street has overlooked the recovery in Sartorius, which he notes has added $800M of value year-to-date for the company. Couillard has a positive bias into the Q4 print and sees a "clear path to margin expansion upside" in 2018. He keeps a Buy rating on Bio-Rad with a $300 price target.

TODAY'S FREE FLY STORIES

SKX

Skechers

$25.79

-7.45 (-22.41%)

10:32
07/20/18
07/20
10:32
07/20/18
10:32
Upgrade
Skechers rating change  »

Standpoint upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPL

Replimune Group

$0.00

(0.00%)

10:32
07/20/18
07/20
10:32
07/20/18
10:32
Syndicate
Replimune Group indicated to open at $15.75, IPO priced at $15.00 »

Replimune Group (REPL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

NYCB

New York Community Bancorp

$11.38

-0.055 (-0.48%)

10:30
07/20/18
07/20
10:30
07/20/18
10:30
Options
Bearish flow in New York Community Bancorp ahead of earnings next week »

Bearish flow in New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$4.75

(0.00%)

10:27
07/20/18
07/20
10:27
07/20/18
10:27
Conference/Events
Intec Pharma management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

OMF

OneMain Holdings

$34.58

0.25 (0.73%)

, VKTX

Viking Therapeutics

$11.31

1.01 (9.81%)

10:27
07/20/18
07/20
10:27
07/20/18
10:27
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

OMF

OneMain Holdings

$34.58

0.25 (0.73%)

VKTX

Viking Therapeutics

$11.31

1.01 (9.81%)

SMTC

Semtech

$51.00

0.2 (0.39%)

AAXN

Axon

$74.65

1.59 (2.18%)

SNOA

Sonoma Pharmaceuticals

$2.44

-0.03 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 14

    Aug

  • 04

    Sep

PM

Philip Morris

$82.73

1.83 (2.26%)

, SKX

Skechers

$26.03

-7.21 (-21.69%)

10:27
07/20/18
07/20
10:27
07/20/18
10:27
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

PM

Philip Morris

$82.73

1.83 (2.26%)

SKX

Skechers

$26.03

-7.21 (-21.69%)

MCK

McKesson

$132.70

-1.1 (-0.82%)

ABC

AmerisourceBergen

$84.82

-0.76 (-0.89%)

ESRX

Express Scripts

$76.34

-0.39 (-0.51%)

FIVE

Five Below

$104.00

-3.8 (-3.53%)

YUMC

Yum China

$34.48

-1.52 (-4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 02

    Aug

  • 10

    Sep

AXP

American Express

$101.23

1.07 (1.07%)

, DUK

Duke Energy

$80.12

-1.08 (-1.33%)

10:27
07/20/18
07/20
10:27
07/20/18
10:27
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

AXP

American Express

$101.23

1.07 (1.07%)

DUK

Duke Energy

$80.12

-1.08 (-1.33%)

AXE

Anixter

$70.25

4.3 (6.52%)

RLI

RLI Corp.

$71.60

1.35 (1.92%)

BECN

Beacon Roofing

$42.89

0.59 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

  • 07

    Aug

  • 08

    Aug

BBT

BB&T

$50.62

0.1 (0.20%)

10:25
07/20/18
07/20
10:25
07/20/18
10:25
Downgrade
BB&T rating change  »

BB&T downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
07/20/18
07/20
10:25
07/20/18
10:25
Conference/Events
Stifel diversified industrials analyst to hold analyst/industry conference call »

Diversified…

NSH

NuStar GP Holdings

$14.05

-0.2 (-1.40%)

10:25
07/20/18
07/20
10:25
07/20/18
10:25
Conference/Events
NuStar GP Holdings to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

10:25
07/20/18
07/20
10:25
07/20/18
10:25
Conference/Events
RBC Capital energy analyst to hold an analyst/industry conference call »

Analyst Scotto, along…

SCHW

Charles Schwab

$52.50

-0.37 (-0.70%)

10:25
07/20/18
07/20
10:25
07/20/18
10:25
Conference/Events
Charles Schwab to hold a webcast »

Management holds 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

SKX

Skechers

$25.68

-7.56 (-22.74%)

10:23
07/20/18
07/20
10:23
07/20/18
10:23
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$9.23

0.4 (4.53%)

10:22
07/20/18
07/20
10:22
07/20/18
10:22
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

CLF

Cleveland-Cliffs

$9.19

0.36 (4.08%)

10:22
07/20/18
07/20
10:22
07/20/18
10:22
Hot Stocks
Cleveland-Cliffs says to consider share buyback, special dividend »

Says to consider share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

CLF

Cleveland-Cliffs

$9.16

0.33 (3.74%)

10:20
07/20/18
07/20
10:20
07/20/18
10:20
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

TSN

Tyson Foods

$64.38

-0.52 (-0.80%)

10:20
07/20/18
07/20
10:20
07/20/18
10:20
Options
Tyson puts active »

Tyson puts active. Shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/20/18
07/20
10:17
07/20/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$9.22

0.39 (4.42%)

10:16
07/20/18
07/20
10:16
07/20/18
10:16
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs: Tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/20/18
07/20
10:16
07/20/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$87.68

-0.05 (-0.06%)

, AMZN

Amazon.com

$1,829.21

16.36 (0.90%)

10:13
07/20/18
07/20
10:13
07/20/18
10:13
Periodicals
Walmart acquiring Shopify 'is no longer a laughable idea', TechCrunch says »

As competition ramps up…

WMT

Walmart

$87.68

-0.05 (-0.06%)

AMZN

Amazon.com

$1,829.21

16.36 (0.90%)

SHOP

Shopify

$174.51

2.83 (1.65%)

EBAY

eBay

$34.58

0.47 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 31

    Jul

  • 16

    Aug

LITE

Lumentum

$53.75

-5.65 (-9.51%)

, OCLR

Oclaro

$8.72

-0.39 (-4.28%)

10:12
07/20/18
07/20
10:12
07/20/18
10:12
Hot Stocks
Optical stocks slip following cautious Q3 outlook from WIN Semi »

WIN Semiconductors, the…

LITE

Lumentum

$53.75

-5.65 (-9.51%)

OCLR

Oclaro

$8.72

-0.39 (-4.28%)

FNSR

Finisar

$17.05

-0.49 (-2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$9.13

0.3 (3.40%)

10:12
07/20/18
07/20
10:12
07/20/18
10:12
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

CLF

Cleveland-Cliffs

$9.14

0.31 (3.51%)

10:11
07/20/18
07/20
10:11
07/20/18
10:11
Hot Stocks
Cleveland-Cliffs cuts FY18 CapEx view to $200M from $225M »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

GOOGL

Alphabet Class A

$1,201.08

1.82 (0.15%)

10:10
07/20/18
07/20
10:10
07/20/18
10:10
Options
Same day call buyers in Google »

Same day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.